patients with malignant lymphoproliferative diseases , ie , chronic lymphocytic leukemia and lymphoma , were found to have higher porphobilinogen deaminase ( pbgd ) activity in their peripheral lymphocytes than normal control subjects , patients with other malignant neoplasms , and patients with various infectious diseases .
C0024299
lymphoma
C0006826
malignant neoplasms